Cost Effectiveness of Denosumab Compared with Oral Bisphosphonates in the Treatment of Post-Menopausal Osteoporotic Women in Belgium
Year of publication: |
2011
|
---|---|
Authors: | Hiligsmann, Mickal ; Reginster, Jean-Yves |
Published in: |
PharmacoEconomics. - Springer Healthcare | Adis, ISSN 1170-7690. - Vol. 29.2011, 10, p. 895-911
|
Publisher: |
Springer Healthcare | Adis |
Subject: | Alendronic-acid | Bisphosphonates | Cost-utility | Denosumab | Osteoporosis | Postmenopausal-osteoporosis | Risedronic-acid |
Extent: | application/pdf text/html |
---|---|
Type of publication: | Article |
Classification: | C - Mathematical and Quantitative Methods ; D - Microeconomics ; I - Health, Education, and Welfare ; Z - Other Special Topics ; I1 - Health ; I19 - Health. Other ; I18 - Government Policy; Regulation; Public Health ; I11 - Analysis of Health Care Markets |
Source: |
-
Fleurence, Rachael L., (2007)
-
Cost Effectiveness of the German Screen-and-Treat Strategy for Postmenopausal Osteoporosis
Mueller, Dirk, (2008)
-
Scotland, Graham, (2011)
- More ...
-
A Systematic Review of Cost-Effectiveness Analyses of Drugs for Postmenopausal Osteoporosis
Hiligsmann, Mickaël, (2015)
-
The clinical and economic burden of non-adherence with oral bisphosphonates in osteoporotic patients
Hiligsmann, Mickaël, (2010)
-
Hiligsmann, Mickael, (2008)
- More ...